Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Prostaglandin inhibitors

From Wikipedia, the free encyclopedia

Prostaglandin inhibitors are drugs that inhibit the synthesis of prostaglandin in human body.[1] There are various types of prostaglandins responsible for different physiological reactions such as maintaining the blood flow instomach andkidney, regulating the contraction ofinvoluntary muscles andblood vessels, and act as a mediator ofinflammation andpain.[2][3]Cyclooxygenase (COX) andPhospholipase A2 are the majorenzymes involved in prostaglandin production, and they are the drug targets for prostaglandin inhibitors.[3] There are mainly 2 classes ofprostaglandin inhibitors, namelynon- steroidal anti- inflammatory drugs (NSAIDs) andglucocorticoids. In the following sections, the medical uses,side effects,contraindications,toxicity and thepharmacology of these prostaglandin inhibitors will be discussed.

Medical Uses

[edit]

Non- steroidal Anti- inflammatory drugs (NSAIDs)

[edit]

NSAIDs are used asanti- inflammatory,antipyretic andanalgesic agents.[4] They can be administered through different routes, namelyoral, rectal andtopical.[4] They can relieve mild to moderate pain.[5] The dosage forms available for different NSAIDs and their respective medical uses are discussed as follows.

The available dosage forms for oral NSAIDs, rectal NSAIDs and topical NSAIDs are shown in the following table.

Oral NSAIDsRectal NSAIDsTopical NSAIDs
Available dosage formsTablets and capsules[6]Suppository[7]Gels, creams and suppository[8]

The common medical uses of oral NSAIDs, rectal NSAIDs and topical NSAIDs are shown in the following table.

Oral NSAIDsRectal NSAIDsTopical NSAIDs
Medical Uses1. Common Cold and Flu

Oral NSAIDs are commonly prescribed for relieving the symptoms ofcommon cold andflu.[9] They are shown to be effective to alleviate symptoms such assneezing,[9]headache,ear pain,muscle pain andmalaise.[10] However, studies show that NSAIDs are not effective in treatingcough andblocked nose.[10]

2.Postoperative Pain

The American Society of Anesthesiologists Task Force on Acute Pain Management recommended the use of oral NSAIDs for managing postoperative pain in 2012.[5] The commonly used NSAIDs for postoperative pain arecelecoxib andibuprofen.[5] Trials have shown that these drugs can reduce pain to at least 50% and they are tolerable by most patients.[5]

3. Migraine

The therapeutic goals for migraine treatment aremigraine prevention and symptomatic relief.[11] The majority of oral NSAIDs such as ibuprofen,mefenamic acid, andindomethacin are shown to be effective to treat and prevent migraine.[11] They do not have significant differences in terms of their therapeutic effects and are almost equally potent in migraine therapy.[11] NSAIDs with less side effects are more preferred in migraine therapy.[11]

Prevention of pancreatitis

Rectal NSAIDs such asdiclofenac andindomethacin are administered for the prevention ofpancreatitis due toendoscopic retrograde cholangiopancreatography (ERCP).[12] ERCP is a technique for treating liver and pancreatic disease.[7]Acute pancreatitis is the most common complication of ERCP. Therefore, rectal NSAIDs are given to patients before ERCP as a measure to prevent post- ERCP pancreatits. Trials showed that rectal NSAIDs are more effective than oral NSAIDs to prevent post ERCP pancreatitis as it exerts its effects faster and its degree of absorption is higher.[7]

Endoscopic retrograde cholangiopancreatography (ERCP)
Osteoarthritis

Topical NSAIDs, mainly diclofenac, are prescribed for patients withosteoarthritis.[8] They are effectively absorbed in arms and knees. As osteoarthritis is a disease commonly found in the elderly (>65 years old), oral NSAIDs are seldom used as their systemic side effects are more severe in elderly patients.[8] Therefore, topical NSAIDs are used for osteoarthritis to exert its localanalgesic effects and minimize their systemic side effects in elderly patients.[8]

Manifestation of osteoarthritis in finger joints

Glucocorticoids

[edit]

Glucocorticoids are potent anti- inflammatory drugs.[10] They are mainly administered via oral and pulmonary route.[10] Oral glucocorticoids are mainly prescribed for the prevention ofchronic disease exacerbation. Inhalable glucocorticoids are effective in treating small airways inflammations.[10] They are commonly used in the maintenance of chronic diseases, and to relieve symptoms duringacute flare up of airway inflammations such asasthma.[10] The dosage forms available for different glucocorticoids and their medical uses are discussed as follows.

The available dosage forms for oral glucocorticoids and inhalable glucocorticoids are shown in the following table.

Oral GlucocorticoidsInhalable Glucocoticoids
Available dosage formsTablets, capsules and liquid[13]Dry powder[14]

The common medical uses of oral glucocorticoids and inhalable glucocorticoids are summarized in the following table.

Oral GlucocorticoidsInhalable Glucocorticoids
Medical usesRheumatoid arthritis

Rheumatoid arthritis is anauto- immune disorder that affectjoints.[15] The common symptoms are warm, painful and swollen joints.[15] Glucocorticoids exert anti- inflammatory effects to relieve the symptoms by inhibiting the synthesis of prostaglandin andleukotriene, and the release ofcollagenase andlysosomal enzymes.[16]

Manifestation of rheumatoid arthritis in finger joints
Asthma

Inhalable glucocorticoids are the major drugs used for asthma treatment and maintenance.[13] They suppress airwayinflammation in asthma by inhibiting prostaglandin synthesis, enhancinggene expression of anti- inflammatory proteins, and suppressing inflammatory genes.[17] They also dilate airway by reducing the production ofleukotriene, a potent bronchoconstrictor in the circulation.[17]

The use of inhalable glucocorticoids in asthma

Side effects

[edit]

NSAIDs

[edit]

The short term use of NSAIDs are rather safe, the manifestations of severe side effects are more commonly seen in the chronic use of NSAIDs.[16]

Renal failure

[edit]

The chronic use of NSAIDs inhibit the synthesis of prostaglandins andthromboxanes, which leads to renalvasoconstriction.[18] This results in a decreased blood flow to the kidneys.[18] Therefore, patients taking NSAIDs in long term are in higher risk of developing chronic renal diseases andnephrotoxicity due to reduced renal perfusion.

Gastric ulcers

[edit]
An image illustrating gastric ulcer

As NSAIDs inhibit prostaglandin synthesis, it reduces the blood flow to the stomach and weakens the stomachmucous membrane, making it more prone togastric acid attack.[18] This increases the risk of developinggastric ulcers.[18] This can be prevented by taking drugs such asproton pump inhibitors,H2 receptor antagonists which suppress gastric acid secretions together with NSAIDs.[18]

Congestive heart failure and hypertension

[edit]

NSAIDs retain sodium and water in the circulation, which in turn increase the blood volume andblood pressure in the body.[18] The production of naturalvasodilator (prostaglandin) is also inhibited at the same time.[18] Hence, the use of NSAIDs is associated with an increased risk ofcongestive heart failure andhypertension especially for elderly patients.[18][19]

Glucocorticoids

[edit]

Side effects in chronic use

[edit]
Glucocorticoid pathway in suppression of HPA axis

The chronic use of glucocorticoids suppress the activity ofhypothalamic- pituitary-adrenal (HPA) axis. The severity of HPA axis suppression is directly proportional to the dose and the duration of therapy.[20] HPA axis suppression results in a weakened immune system, making the patients more prone to infections in long term.[20]

Side effects in short-term use

[edit]

Short- term use of glucocorticoids creates minor disturbance in human body. The examples of short- term effects created by glucocorticoids arehyperglycemia, oscillation in blood pressure, psychiatric events and electrolyte disorders.[21] These effects usually can be reversed once the glucocorticoids therapy is stopped.[20]

Contraindications

[edit]

NSAIDs

[edit]

Patients taking Anticoagulants

[edit]

As NSAIDs inhibitcyclooxygenase, the production ofthromboxane, a natural coagulator, is inhibited.[22] Therefore, the risk of bleeding during the use of NSAIDs is intensified by concomitant use ofanticoagulants.[22]

Patients with Chronic Renal Diseases

[edit]

As NSAIDs reduce blood flow to kidney by inhibiting prostaglandin synthesis, it leads torenal ischemia and a decrease inglomerular filtration pressure.[22] As a result, the kidney functions of patients withchronic renal diseases is further worsen.[22]

Glucocorticoids

[edit]

Patients with Systemic Fungal Infections

[edit]

Glucocorticoids reduces the number of healthyneutrophils in human body, leading toneutropenia.[23] Neutropenia reduces the efficacy ofantifungal drugs.[23] Studies show that neutropenia together with high cumulative glucocorticoid concentration in circulation reduce the efficacy of invasive fungal infection treatment.[23] Therefore, patients with fungal infections are not recommended with the use of glucocorticoids.[23]

Patients with Diabetes Mellitus

[edit]

Glucocorticoids raise blood glucose level via different mechanisms. They can stimulateendogenous glucose production by activating the genes involved; reduce glucose uptake by muscle andadipose tissue; induce muscle and adipose tissues to produce substrates involved in glucose production and inhibit the section and production ofinsulin in pancreaticβ cells.[24] All these raise blood glucose level and exacerbatediabetes mellitus.[24] Thus, the use of glucocorticoids should be minimized or avoided for diabetes patients.

Toxicity

[edit]

NSAIDs

[edit]

The most common signs of NSAIDs overdose arenausea,vomiting, blurred vision anddrowsiness.[16] NSAIDs toxicity can be reversed bygastric lavage.[16] In severe cases, NSAIDs toxicity can lead to the following clinical conditions.

Central Nervous System (CNS) toxicity

[edit]
Manifestation of nystagmus

NSAIDs overdose can lead to acutecentral nervous system toxicity.[16] It can create CNS effects ranging fromdrowsiness tocoma.[16] Other symptoms such asataxia,nystagmus,headaches,seizure, anddisorientation are also the reported manifestations of CNS toxicity.[16]

Acid- Base abnormalities

[edit]

A large dose of NSAIDs, particularlyibuprofen,naproxen can lead tometabolic acidosis.[16] Metabolic acidosis can further deteriorate intocardiac arrhythmia andelectrolyte imbalance which can be fatal.[16]

Glucocorticoids

[edit]

The overdose of glucocorticoids exacerbate its side effects. Most of the toxicities induced can be reversed by discontinuing the therapy.[16]

Cushing's Syndrome

[edit]

A high dose of glucocorticoids suppress the release ofcorticotropin from thepituitary, leading toCushing's Syndrome.[16] The symptoms are weight gain on the upper back and the area between shoulders, thinning of arms and legs, and moon face.[16]

Symptoms of Cushing's Syndrome.

Weakening the immune system

[edit]

High- dose glucocorticoids increase the risk of patients' infection bybacteria,virus andfungus.[16] The cells involved in theimmune system are mainlyphagocytes,neutrophils,monocytes,macrophages,natural killer cells,B cells,T cells,eosinophils,basophils andmast cells. Glucocorticoids significantly reduce the production of these cells in the human body, thereby weakening the immune system.[16]

Pharmacology

[edit]

Pharmacokinetics

[edit]

Pharmacokinetics refers to the study of absorption, distribution, metabolism and elimination of drugs in human body.[25]

NSAIDs[18]Glucocortiocids[26]
AbsorptionA majority of NSAIDs have good oral absorption.

(Degree of absorption ranged from 55%- 100%)

Most glucocorticoids have good oral absorption

(Degree of absorption ranged from 60% to 100%)

DistributionNSAIDs are highly bound toplasma proteins, making them more difficult to distribute to the site of actions.Glucocorticoids are distributed by binding withprotein, mainlyglycoprotein,transcortin andalbumin.
MetabolismThe majority of NSAIDs undergoglucoronidation duringphase II metabolism in the liverGlucocorticoids undergophase I andphase II metabolism in theliver. The common phase I metabolisms that glucocorticoids undergo areoxidation andhydrogenation. Glucocorticoids undergoglucoronidation andsulphation during phase II metabolism in the liver
EliminationRenal ExcretionRenal Excretion

Pharmacodynamics

[edit]

Pharmacodynamics refers to the study of how the drugs exert their actions in human body.[27]

NSAIDs

[edit]

NSAIDs inhibits the synthesis of prostaglandin by inhibitingcyclooxygenase (COX-1 andCOX-2). NSAIDs with higher selectivity onCOX-2 such asindomethacin,zomepirac anddiclofenac have potent anti- inflammatory activity and fewer side effects on stomach and kidney.[28][29]

Glucocorticoids

[edit]

Phospholipase A2 is an enzyme to catalyze the release ofarachidonic acid in our body. After arachidonic acid is released, it can be converted to prostaglandins by cyclooxygenase.[28] Glucocorticoids work by inhibiting phospholipase A2, hence indirectly inhibiting prostaglandin synthesis.[28]

References

[edit]
  1. ^Yazid, Samia; Norling, Lucy V.; Flower, Rod J. (2012-08-01)."Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system".Prostaglandins & Other Lipid Mediators. Eicosanoids in Cardiovascular Disease.98 (3):94–100.doi:10.1016/j.prostaglandins.2011.11.005.ISSN 1098-8823.PMID 22123264.
  2. ^Green, Gary A. (2001-01-01)."Understanding NSAIDs: From aspirin to COX-2".Clinical Cornerstone.3 (5):50–59.doi:10.1016/S1098-3597(01)90069-9.ISSN 1098-3597.PMID 11464731.
  3. ^abRicciotti Emanuela; FitzGerald Garret A. (2011-05-01)."Prostaglandins and Inflammation".Arteriosclerosis, Thrombosis, and Vascular Biology.31 (5):986–1000.doi:10.1161/ATVBAHA.110.207449.PMC 3081099.PMID 21508345.
  4. ^abGhlichloo, Ida; Gerriets, Valerie (2021),"Nonsteroidal Anti-inflammatory Drugs (NSAIDs)",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 31613522, retrieved2021-03-12
  5. ^abcdGupta, Anita; Bah, Maimouna (2016-11-13)."NSAIDs in the Treatment of Postoperative Pain".Current Pain and Headache Reports.20 (11): 62.doi:10.1007/s11916-016-0591-7.ISSN 1534-3081.PMID 27841015.S2CID 22599479.
  6. ^Goldstein, Jay L; Cryer, Byron (2015-01-22)."Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies".Drug, Healthcare and Patient Safety.7:31–41.doi:10.2147/DHPS.S71976.ISSN 1179-1365.PMC 4310346.PMID 25653559.
  7. ^abcHou, Yi-Chao; Hu, Qiang; Huang, Jiao; Fang, Jing-Yuan; Xiong, Hua (2017-04-25)."Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis".Scientific Reports.7 (1): 46650.Bibcode:2017NatSR...746650H.doi:10.1038/srep46650.ISSN 2045-2322.PMC 5404221.PMID 28440297.
  8. ^abcdArgoff, Charles E; Gloth, F Michael (2011)."Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients".Therapeutics and Clinical Risk Management.7:393–399.doi:10.2147/TCRM.S24458.ISSN 1176-6336.PMC 3208405.PMID 22076115.
  9. ^abKim, Soo Young; Chang, Yoon-Jung; Cho, Hye Min; Hwang, Ye-Won; Moon, Yoo Sun (2015-09-21)."Non-steroidal anti-inflammatory drugs for the common cold".The Cochrane Database of Systematic Reviews.2015 (9): CD006362.doi:10.1002/14651858.CD006362.pub4.ISSN 1469-493X.PMC 10040208.PMID 26387658.
  10. ^abcdef"UpToDate".www.uptodate.com. Retrieved2021-03-12.
  11. ^abcdBecker, Werner J. (2015)."Acute Migraine Treatment in Adults".Headache: The Journal of Head and Face Pain.55 (6):778–793.doi:10.1111/head.12550.ISSN 1526-4610.PMID 25877672.S2CID 23327034.
  12. ^Yu, Lei-Min; Zhao, Ke-Jia; Lu, Bin (2018-02-08)."Use of NSAIDs via the Rectal Route for the Prevention of Pancreatitis after ERCP in All-Risk Patients: An Updated Meta-Analysis".Gastroenterology Research and Practice.2018:1–10.doi:10.1155/2018/1027530.ISSN 1687-6121.PMC 5822867.PMID 29576766.
  13. ^ab"UpToDate".www.uptodate.com. Retrieved2021-03-28.
  14. ^Daley-Yates, Peter T. (2015)."Inhaled corticosteroids: potency, dose equivalence and therapeutic index".British Journal of Clinical Pharmacology.80 (3):372–380.doi:10.1111/bcp.12637.ISSN 1365-2125.PMC 4574823.PMID 25808113.
  15. ^abFirestein, Gary S.; McInnes, Iain B. (2017-02-21)."Immunopathogenesis of Rheumatoid Arthritis".Immunity.46 (2):183–196.doi:10.1016/j.immuni.2017.02.006.ISSN 1074-7613.PMC 5385708.PMID 28228278.
  16. ^abcdefghijklmn"UpToDate".www.uptodate.com. Retrieved2021-03-13.
  17. ^abBarnes, Peter J. (1998-10-01)."Efficacy of inhaled corticosteroids in asthma".Journal of Allergy and Clinical Immunology.102 (4):531–538.doi:10.1016/S0091-6749(98)70268-4.ISSN 0091-6749.PMID 9802359.
  18. ^abcdefghiWongrakpanich, Supakanya; Wongrakpanich, Amaraporn; Melhado, Katie; Rangaswami, Janani (2018-02-01)."A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly".Aging and Disease.9 (1):143–150.doi:10.14336/AD.2017.0306.ISSN 2152-5250.PMC 5772852.PMID 29392089.
  19. ^Varga, Zoltan; Sabzwari, Syed rafay ali; Vargova, Veronika (2017)."Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue".Cureus.9 (4): e1144.doi:10.7759/cureus.1144.ISSN 2168-8184.PMC 5422108.PMID 28491485.
  20. ^abcGordijn, M. S., Rensen, N., Gemke, R. J., van Dalen, E. C., Rotteveel, J., & Kaspers, G. J. (2015). Hypothalamic‐pituitary‐adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.Cochrane Database of Systematic Reviews, (8).
  21. ^Williams, Dennis M. (2018-06-01)."Clinical Pharmacology of Corticosteroids".Respiratory Care.63 (6):655–670.doi:10.4187/respcare.06314.ISSN 0020-1324.PMID 29794202.S2CID 44128968.
  22. ^abcdSaxena, Aaruni; Balaramnavar, Vishal M.; Hohlfeld, Thomas; Saxena, Anil K. (2013-12-05)."Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets".European Journal of Pharmacology.721 (1):215–224.doi:10.1016/j.ejphar.2013.09.032.ISSN 0014-2999.PMID 24075938.
  23. ^abcdLionakis, Michail S; Kontoyiannis, Dimitrios P (2003-11-29)."Glucocorticoids and invasive fungal infections".The Lancet.362 (9398):1828–1838.doi:10.1016/S0140-6736(03)14904-5.ISSN 0140-6736.PMID 14654323.S2CID 12087010.
  24. ^abKwon, Soonho; Hermayer, Kathie L.; Hermayer, Kathie (2013-04-01)."Glucocorticoid-Induced Hyperglycemia".The American Journal of the Medical Sciences.345 (4):274–277.doi:10.1097/MAJ.0b013e31828a6a01.ISSN 0002-9629.PMID 23531958.S2CID 46056913.
  25. ^Hamidi, Mehrdad; Azadi, Amir; Rafiei, Pedram; Ashrafi, Hajar (2013)."A Pharmacokinetic Overview of Nanotechnology-Based Drug Delivery Systems: An ADME-Oriented Approach".Critical Reviews in Therapeutic Drug Carrier Systems.30 (5):435–467.doi:10.1615/CritRevTherDrugCarrierSyst.2013007419.ISSN 0743-4863.PMID 24099328.
  26. ^Czock, David; Keller, Frieder; Rasche, Franz Maximilian; Häussler, Ulla (2005)."Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids".Clinical Pharmacokinetics.44 (1):61–98.doi:10.2165/00003088-200544010-00003.ISSN 0312-5963.PMID 15634032.S2CID 24458998.
  27. ^Keller, Frieder; Hann, Alexander (2018-09-07)."Clinical Pharmacodynamics".Clinical Journal of the American Society of Nephrology.13 (9):1413–1420.doi:10.2215/CJN.10960917.ISSN 1555-9041.PMC 6140566.PMID 29769182.
  28. ^abcVane, J. R.; Botting, R. M. (1998-10-01)."Anti-inflammatory drugs and their mechanism of action".Inflammation Research.47 (2):78–87.doi:10.1007/s000110050284.ISSN 1420-908X.PMID 9831328.S2CID 1866687.
  29. ^Zarghi, Afshin; Arfaei, Sara (2011)."Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships".Iranian Journal of Pharmaceutical Research.10 (4):655–683.ISSN 1735-0328.PMC 3813081.PMID 24250402.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Prostaglandin_inhibitors&oldid=1264062887"
Category:

[8]ページ先頭

©2009-2025 Movatter.jp